Document Detail


Open versus closed vitrification of blastocysts from an oocyte-donation programme: a prospective randomized study.
MedLine Citation:
PMID:  23507132     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The use of open carriers for embryo vitrification has raised safety concerns and therefore vitrification in closed systems has been proposed. However, the drop in the cooling rate emerges as a major drawback. The objective of the present study was to compare the efficiency of vitrification in open versus closed conditions. Blastocysts were randomly allocated either to open ultra-rapid vitrification (group I) or closed aseptic vitrification (group II). In group I, blastocysts were exposed to two solutions of ethylene glycol/dimethylsulphoxide (10%/10% and 20%/20%), while in group II, blastocysts were pretreated with a solution of lower concentration (5%/5%). A total of 208 and 224 vitrification-warming cycles were performed for groups I and II, respectively. Both groups were equal in terms of maternal age, sperm parameters and number and quality of blastocysts vitrified, warmed and transferred per cycle. Importantly, there was no significant difference between the groups in the analysed outcomes; embryo survival rate (84.1% versus 82.1%), clinical pregnancy rate (45.9% versus 42.4%), implantation rate (25.6% versus 24.5%), cycle cancellation rate (6.7% versus 8.5%) and live birth rate (41.2% versus 41.0%). These data suggest that ultra-rapid vitrification may be replaced by aseptic vitrification without affecting clinical efficiency. Vitrification is defined as the solidification of a liquid without the formation of ice crystals. The basic principle lies in finding the correct balance between the intracellular amount of cryoprotectants and the cooling rate, without inducing a toxic effect. Before plunging in liquid nitrogen, the embryos are deposited on a carrier device that can be described as open or closed. The use of open carriers have raised safety concerns and therefore vitrification in closed systems has been proposed. However, the drop in the cooling rate emerges as a major drawback. The objective of the present study was to analyse the outcome of vitrification of blastocysts randomly allocated to either open vitrification (group I) or aseptic vitrification (group II) using the VitriSafe as the embryo carrier in both groups. In group I, blastocysts were exposed to two cryoprotectant solutions of ethylene glycol/dimethylsulphoxide (10%/10% and 20%/20%), while in group II, blastocysts were initially exposed to an additional solution of lower concentration (5%/5%). A total of 208 and 224 vitrification-warming cycles were initiated for group I and group II, respectively. Both groups were equal in terms of maternal age, sperm parameters and number and quality of blastocysts vitrified, warmed and transferred per cycle. There was no statistically significant difference between the two groups in the analysed outcomes; embryo survival rate (84.1% versus 82.1%), clinical pregnancy rate (45.9% versus 42.4%), implantation rate (25.6% versus 24.5%), cycle cancellation rate (6.7% versus 8.5%) and live birth rate (41.2% versus 41.0%). Ultra-rapid vitrification can be replaced by aseptic vitrification without affecting cryopreservation efficiency.
Authors:
Y Panagiotidis; P Vanderzwalmen; Y Prapas; E Kasapi; M Goudakou; A Papatheodorou; T Passadaki; S Petousis; N Nikolettos; S Veletza; N Prapas; G Maroulis
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-9
Journal Detail:
Title:  Reproductive biomedicine online     Volume:  -     ISSN:  1472-6491     ISO Abbreviation:  Reprod. Biomed. Online     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-3-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101122473     Medline TA:  Reprod Biomed Online     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Affiliation:
Iakentro Advanced Medical Centre, IVF Unit, Thessaloniki, Greece; Democritus University of Thrace, Medical School, Alexandroupolis, Greece. Electronic address: panagy@iakentro.gr.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fatigue in Parkinson's Disease: Measurement Properties of a Generic and a Condition-specific Rating ...
Next Document:  Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment prot...